Knowledge Hub
Learn how we're pioneering a new wave of precision medicine, explore our collection of publications, disease studies, webinars, thought leadership, and more
Featured

COVID-19 Disease Study
Newsletter signup
Blog
Our Philosophy
A deep dive into our unique approach and our mission to find better treatment options for patients with unmet medical needs
Publication
Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis
Groundbreaking study published in the Journal of Translational Medicine provides the first detailed genetic insights into the mechanisms underpinning ME/CFS
Disease Study
COVID-19 Disease Study
Understanding the disease biology of COVID-19 to find novel drug targets and new treatment options
Webinar
Disease Mechanisms and Novel Target Discovery
Watch on-demand as PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji, to explore disease mechanisms and novel target discovery
Blog
The Best of PrecisionLife in 2022
2022 was a memorable year for techbio and PrecisionLife. Here we look back at twelve of our highlights.
Publication
Cell Patterns: INDx Systematic Indication Extension
Paper demonstrating the potential of indication extension to systematically reposition hundreds of drugs into new indications
Publication
Combinatorial analytics: An Essential Tool for the Delivery of Precision Medicine
An Opinion, published in the new Open Access Journal Artificial Intelligence in the Life Sciences from Elsevier, describes the need to extend our current analytical methods to effectively interrogate population data sets
Disease Study
Alzheimer's Disease Study
Reducing the risk of future Alzheimer's disease clinical trial failures by identifying patient subgroups
Blog
Proving the Power of Combinatorial Analytics
A summary of how >70% of associated novel gene targets for severe COVID-19 identified with combinatorial analytics in May 2020 have now been independently validated
Sign Up